Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A pivotal trial of LiPlaCis in breast cancer

Trial Profile

A pivotal trial of LiPlaCis in breast cancer

Phase of Trial: Phase II

Latest Information Update: 02 Jul 2018

At a glance

  • Drugs Cisplatin (Primary)
  • Indications Advanced breast cancer
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 02 Jul 2018 According to a Medical Prognosis Institute media release, the Company discussed the proposed design of a pivotal (aimed for marketing approval) randomized trial of LiPlaCis for metastatic breast cancer. DKMA indicated that the planned clinical trial will be considered a pivotal Phase II study if it is accepted for the EMA PRIME program.
    • 27 May 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top